The mark consists of an animated sequence beginning with the stylized letters OMB, displayed at a forty-five degree tilt, with the "O" in coral and the combined letters "MB" in teal followed by the word KESIMPTA in a stylized brown font beginning with the letters SIMP in the middle with the letters KE descending from the top left and the letters TA rising from the bottom right [Freeze Frames 1 and 2] followed by a pulse of light effect [Freeze Frame 3] followed by the gradual appearance of the words "(ofatumumab) 20 mg injection" (Freeze Frames 4 and 5]. The color white is not claimed and appears as background only.